1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Italy >
  5. Scinai Acquires PinCell

M&A Deal Summary

Scinai Acquires PinCell

On March 27, 2025, Scinai acquired life science company PinCell

Acquisition Highlights
  • This is Scinai’s 1st transaction in the Life Science sector.
  • This is Scinai’s 1st transaction in Italy.

M&A Deal Summary
Date 2025-03-27
Target PinCell
Sector Life Science
Buyer(s) Scinai
Deal Type Add-on Acquisition

Target

PinCell

Milan, Italy
PinCell is a biotechnology company targeting a novel pathological pathway to develop first-in-class anti-inflammatory therapies for the treatment of rare, severe, and highly undertreated skin diseases. PinCell was formed in 2008 and is based in Milan, Italy.

Search 208,895 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Scinai

Jerusalem, Israel
Category Company
Sector Life Science
DESCRIPTION

Scinai is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with an innovative, de-risked pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique Biologics CDMO providing biological drug development, analytical methods development, clinical GMP manufacturing, and pre-clinical and clinical trial design and execution services to early stage biotech companies. Scinai is based in Jerusalem, Israel.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal